Why the study?
Do molsidomine and its active metabolites (SIN-1, SIN-1A) improve hemodynamic parameters and reduce arrhythmias in experimental rat models?
Population
2 experimental models in rats (Langendorff heart study and ischemia-reperfusion-induced arrhythmias model)
Comparison
Molsidomine, SIN-1, SIN-1A, and lidocaine vs Control
Design
Preclinical
Authors
Loading...
May support SIN-1A cardioprotection in rat models; leaves open translation to human invasive procedures.
Do molsidomine and its active metabolites (SIN-1, SIN-1A) improve hemodynamic parameters and reduce arrhythmias in experimental rat models?
The molsidomine active metabolite SIN-1A demonstrates potential direct cardioprotective action in experimental rat models, suggesting possible utility in invasive cardiology procedures.
Żorniak et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: